Bml Capital Management, LLC Cyteir Therapeutics, Inc. Transaction History

Bml Capital Management, LLC

  • $170 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
BUY
$3.0 - $3.15 $1.21 Million - $1.27 Million
404,045 Added 12.43%
3,654,053 $11 Billion
Q3 2023

Oct 23, 2023
BUY
$2.71 - $2.84 $21 - $22
8 Added 0.0%
3,250,008 $9.23 Billion
Q2 2023

Jul 24, 2023
BUY
$1.74 - $2.6 $180,444 - $269,630
103,704 Added 3.3%
3,250,000 $8.45 Billion
Q1 2023

Apr 14, 2023
BUY
$1.47 - $1.84 $4.63 Million - $5.79 Million
3,146,296 New
3,146,296 $5.73 Billion

Others Institutions Holding CYT

# of Institutions
2
Shares Held
2.47M
Call Options Held
0
Put Options Held
0
View Full List

About Cyteir Therapeutics, Inc.

CYT Quotes by TradingView
  • Ticker CYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,413,400
  • Market Cap $107M
  • Description
  • Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...
More about CYT
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email